0(2),2'-anhydrouridine,
cyclouridine,
3736-77-4,
Cyclouridine,
2,2'-Cyclouridine,
O2,2'-Cyclouridine,
2,2'-Anhydro-1(beta-D-arabinofuranosyl)uracil,
2,2'-Anhydrouridine,
2,2'-O-Cyclouridine,
MFCD00004945,
2,2-Anhydro-1(b-D-arabinofuranosyl)uracil,
2,2'-Anhydro-1(B-D-arabinofuranosyl)uracil,
2,2'-Anhydro-(1-Beta-D-Arabinofuranosyl)uracil,
2,2;-Cyclouridine,
NSC 157148,
2,2'-Anhydro(1-beta-D-arabinofuranosyl)uracil,
O2,2'-Cyclouridine (VAN),
NSC157148,
AK-34907,
EINECS 223-107-6,
2,2'Anhydrouridine,
Oc,2'-cyclouridine,
2,2' Anhydrouridine,
2,2'-anhydro uridine,
2, 2'-Anhydrouridine,
2,2'-O-Anhydro-(1-beta-D-arabofuranosyl)uracil,
AC1LFO1Z,
Anhydrouridine; 2,2'-ANHYDROURIDINE; CYCLOURIDINE,
O2,2'-Cyclouridine, 99%,
SCHEMBL1883172,
CHEMBL3251336,
UUGITDASWNOAGG-CCXZUQQUSA-,
UUGITDASWNOAGG-CCXZUQQUSA-N,
ZINC315929,
AC1Q6974,
ACT02892,
BJE,
AKOS015896944,
CCG-252211,
CS-W013029,
DB04627,
HY-W012313,
MCULE-6351000710,
2,2''-Anhydrouridine; NSC 157148,
AJ-19191,
AS-15433,
BR-34907,
P304,
ZB010385,
AB0016929,
AX8007897,
ST2415559,
TL8006497,
FT-0634994,
2,2'-Anhydro(beta-D-arabinofuranosyl) uracil,
2,2'-Anhydro-1($b-D-arabinofuranosyl)uracil,
2'-Anhydro(1-.beta.-D-arabinofuranosyl)uracil,
2,2'-Anhydro-1(|?-D-arabinofuranosyl)uracil,
K-8242,
2,2\'-O-Anhydro-(1--D-arabinofuranosyl)uracil,
736O774,
J-700011,
W-106545,
BRD-K46900527-001-01-4,
(2R,3R,3aS,9aR)-2,3,3a,9a-Tetrahydro-3-hydroxy-2-(hydroxymethyl)-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one,
(2R,3R,3aS,9aR)-3-hydroxy-2-(hydroxymethyl)-2,3,3a,9a-tetrahydro-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one,
(2R,3R,3aS,9aR)-3-hydroxy-2-(hydroxymethyl)-2,3,3a,9a-tetrahydrofuro[[?]:[?]]oxazolo[[?]]pyrimidin-6-one,
(2R-(2alpha,3beta,3Abeta,9abeta))-2,3,3a,9a-tetrahydro-3-hydroxy-(hydroxymethyl)-6H-furo(2',3':4,5)oxazolo(3,2-a)pyrimidin-6-one,
6H-Furo(2',3':4,5)oxazolo(3,2-a)pyrimidin-6-one, 2,3,3a,9a-tetrahydro-3-hydroxy-2-(hydroxymethyl)-, (2R-(2alpha,3beta,3abeta,9abeta))- (9CI),
6H-Furo(2',3':4,5)oxazolo(3,2-a)pyrimidin-6-one, 2,3,3a,9a-tetrahydro-3-hydroxy-2-(hydroxymethyl)-, stereoisomer (VAN) (8CI),
6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one, 2,3,3a,9a-tetrahydro-3-hydroxy-2-(hydroxymethyl)-, (2R,3R,3aS,9aR)-,
InChI=1/C9H10N2O5/c12-3-4-6(14)7-8(15-4)11-2-1-5(13)10-9(11)16-7/h1-2,4,6-8,12,14H,3H2/t4-,6-,7+,8-/m1/s1,
C9H10N2O5,
cc-301,
AR-1K8691,
C9-H10-N2-O5,
CID806138,
2,2'-Anhydro-1(|A-D-arabinofuranosyl)uracil,
2,2'-O-Cyclouridine, 98% - 25G 25g,
2,2'-Anhydro-(1-Beta-D-Ribofuranosyl)uracil,
ANU,
(2R,3R,3aS,9aR)-2,3,3a,9a-Tetrahydro-3-hydroxy-2-(hydroxymethyl)-6H-furo[2 inverted exclamation mark ,3 inverted exclamation mark :4,5]oxazolo[3,2-a]pyrimidin-6-one,
[2R-(2alpha,3beta,3abeta,9abeta)]-2,3,3a,9a-tetrahydro-3-hydroxy-(hydroxymethyl)-6H-furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one,
64183-27-3,
6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidin-6-one, 2,3,3a,9a-tetrahydro-3-hydroxy-2-(hydroxymethyl)-, [2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.)]-,